Researching Functioning, Disability And Rehabilitation
Funder
National Health and Medical Research Council
Funding Amount
$387,469.00
Summary
The research program investigates the causes and treatments that help people overcome disability and improve functioning, particularly in life areas such as home, family, community and work.
Mild traumatic brain injury (TBI) is a leading cause of death and disability in Australia, especially in young populations. Although many patients recover uneventfully following mild TBI, complications such as prolonged symptoms, depression and cognitive deterioration may occur. With considerable advancements in neuroimaging and cognitive assessment in recent years, newer techniques may provide a window to directly observe changes that accompany mild TBI.
Working With Indigenous Services And Communities To Reduce The Harms From Alcohol
Funder
National Health and Medical Research Council
Funding Amount
$474,513.00
Summary
Indigenous Australians face up to eight times the rate of hospitalisation for alcohol-related conditions. Reducing this burden will be key to closing the health gap. Professor Kate Conigrave will build on longstanding partnerships with Indigenous communities, services and health professionals to conduct a 5-year program of work aimed at improving treatment and prevention of alcohol problems. This will span settings including Indigenous primary health services, prisons and whole communities.
Improving Diagnosis, Treatment And Prevention Of Mitochondrial Disease
Funder
National Health and Medical Research Council
Funding Amount
$487,891.00
Summary
The goal of this work is to use state-of-the-art research methods to improve clinical practice and the health outcomes for patients with mitochondrial disease and other neurological disorders. Professor Sue will undertake an integrated program involving clinical studies, bioinformatics, tissue culture and in vitro cell modelling to discover better ways to treat mitochondrial disease and other neurological diseases due to impaired mitochondrial function.
Using Mouse Models To Identify Better Therapies For Acute Leukemia And Myelodysplasia
Funder
National Health and Medical Research Council
Summary
Despite great advances in the understanding of the genes that cause cancers of the blood, cure rates for patients with acute leukemia, or a more indolent form called myelodyspslaia, has not improved significantly over the last 20 years, with the majority of patients dying from resistant or recurrent disease within 5 years. Our research will use mouse models of acute leukemia and myelodysplasia to identify the critical genetic pathways that drive these diseases and to design and test new therapie ....Despite great advances in the understanding of the genes that cause cancers of the blood, cure rates for patients with acute leukemia, or a more indolent form called myelodyspslaia, has not improved significantly over the last 20 years, with the majority of patients dying from resistant or recurrent disease within 5 years. Our research will use mouse models of acute leukemia and myelodysplasia to identify the critical genetic pathways that drive these diseases and to design and test new therapies that can be taken into clinical trials.Read moreRead less